November 2009 Volume 16 Number 11, pp 807 - 872
---------------------------------------------------------------------
New in January 2010: Cell Death & Disease
http://links.ealert.nature.com/ctt?kn=34&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Online. Open access. Author pays.
Brought to you by the editorial team of Cell Death & Differentiation,
Cell Death & Disease is a peer-reviewed author-pays online journal that
publishes full-length papers, reviews, and commentaries describing
original research in the field of translational cell death.
Sign up today for Cell Death & Disease's ToC-alert at
http://links.ealert.nature.com/ctt?kn=28&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
and be notified when the journal launches in January 2010.
---------------------------------------------------------------------
Advance Online Publication
http://links.ealert.nature.com/ctt?kn=7&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Articles for this journal are published online ahead of print through
Advance Online Publication (AOP), meaning that the latest research
reaches you in the timeliest way possible. Check the AOP webpage each
week to make sure that you are not left behind:
http://links.ealert.nature.com/ctt?kn=7&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
----------------------
MINI REVIEW
----------------------
Comparative assessment of siRNA and shRNA off target effects: what is
slowing clinical development
D D Rao, N Senzer, M A Cleary and J Nemunaitis
Abstract: http://links.ealert.nature.com/ctt?kn=39&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=11&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
RNA interference-mediated knockdown of p21WAF1 enhances anti-tumor cell
activity of oncolytic adenoviruses
M Shiina, M D Lacher, C Christian and W M Korn
Abstract: http://links.ealert.nature.com/ctt?kn=12&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=13&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Lentiviruses with trastuzumab bound to their envelopes can target and
kill prostate cancer cells
K-x Zhang, M Moussavi, C Kim, E Chow, I S Chen, L Fazli, W Jia and
P S Rennie
Abstract: http://links.ealert.nature.com/ctt?kn=14&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=1&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Cytotoxicity of adenoviruses expressing the wild-type p53 gene to esophageal
carcinoma cells is linked with the CAR expression level and indirectly with
the endogenous p53 status
G Ma, K Kawamura, Q Li, N Suzuki, M Liang, M Namba, H Shimada and M Tagawa
Abstract: http://links.ealert.nature.com/ctt?kn=3&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=4&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Combination of human tumor necrosis factor-alpha (hTNF-[alpha]) gene delivery
with gemcitabine is effective in models of pancreatic cancer
S R Murugesan, C R King, R Osborn, W R Fairweather, E M O'Reilly, M O Thornton
and L L Wei
Abstract: http://links.ealert.nature.com/ctt?kn=5&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=8&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects
on carcinomas
L Vardouli, C Lindqvist, K Vlahou, A S I Loskog and A G Eliopoulos
Abstract: http://links.ealert.nature.com/ctt?kn=41&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=42&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Novel strategies to augment genetically delivered immunotoxin molecular therapy
for cancer therapy
X Liu, J Wu, S Zhang, C Li and Q Huang
Abstract: http://links.ealert.nature.com/ctt?kn=43&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=45&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
---------------------------------------------------------------------
JHG Editor's Choice:
Innovative genetic advancement
Journal of Human Genetics (JHG) is proud to feature Editor's Choice:
Innovative genetic advancement - an original collection of articles and
reviews on the most recent, important developments in the field. This
web focus features a variety of articles covering:
- The first genome-wide association study
- Disease susceptibility genes
- Towards personalized medicine
- Population specificity and genome diversity
Access this limited-time web focus today!
http://links.ealert.nature.com/ctt?kn=26&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=32&m=34296792&r=MTc3MTg1MDcyMQS2&b=2&j=NTk2NzAwNjUS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
